HomeTagsChemoproteomic technology

chemoproteomic technology

BridGene Biosciences Announces Research Collaboration with the Peter MacCallum Cancer Centre to Discover Targets and Small Molecule Drug Candidates for Ovarian Cancer

BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules for high value, traditionally undruggable targets, announced...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics